Alzheimer s & Dementia,
Journal Year:
2023,
Volume and Issue:
19(7), P. 3233 - 3234
Published: April 20, 2023
Abstract
Although
there
is
a
clear
link
between
lifestyle
and
cognitive
health,
the
dissonance
observational
intervention
studies
results
reveals
gaps
in
knowledge
of
how
to
translate
healthy
lifestyles
into
better
health
for
population.
This
letter
discusses
interpreting
linking
older
adults.
The
main
goal
briefly
highlight
necessity
understanding
incorporating
intrinsic
extrinsic
drivers
engagement
before
prescribing
implementing
individual
multicomponent
programs.
JAMA Internal Medicine,
Journal Year:
2023,
Volume and Issue:
184(1), P. 54 - 54
Published: Nov. 27, 2023
Importance
Modifiable
risk
factors
are
hypothesized
to
account
for
30%
40%
of
dementia;
yet,
few
trials
have
demonstrated
that
risk-reduction
interventions,
especially
multidomain,
efficacious.
Objective
To
determine
if
a
personalized,
multidomain
reduction
intervention
improves
cognition
and
dementia
profile
among
older
adults.
Design,
Setting,
Participants
The
Systematic
Multi-Domain
Alzheimer
Risk
Reduction
Trial
was
randomized
clinical
trial
with
2-year
intervention.
A
total
172
adults
at
elevated
(age
70-89
years
≥2
8
targeted
factors)
were
recruited
from
primary
care
clinics
associated
Kaiser
Permanente
Washington.
Data
collected
August
2018
2022
analyzed
October
September
2023.
Intervention
randomly
assigned
the
(personalized
goals
health
coaching
nurse
visits)
or
education
control.
Main
Outcomes
Measures
outcome
change
in
composite
modified
Neuropsychological
Test
Battery;
preplanned
secondary
outcomes
quality
life
(QOL).
assessed
baseline
6,
12,
18,
24
months.
Linear
mixed
models
used
compare,
by
intention
treat,
average
treatment
effects
(ATEs)
over
follow-up.
initially
person
but
then,
due
onset
COVID-19
pandemic,
remote.
Results
participants
had
mean
(SD)
age
75.7
(4.8)
years,
108
(62.8%)
women.
After
2
compared
90
control
group,
82
larger
improvements
cognitive
score
(ATE
SD,
0.14;
95%
CI,
0.03-0.25;
P
=
.02;
74%
improvement
group),
better
factor
0.11;
0.01-0.20;
.03),
improved
QOL
(ATE,
0.81
points;
−0.21
1.84;
.12).
There
no
between-group
differences
serious
adverse
events
(24
group
23
group;
.59),
greater
treatment-related
such
as
musculoskeletal
pain
(14
vs
0
<
.001).
Conclusions
Relevance
In
this
trial,
2-year,
led
modest
cognition,
factors,
QOL.
strategies
should
be
considered
dementia.
Registration
ClinicalTrials.gov
Identifier:
NCT03683394
Alzheimer s & Dementia Translational Research & Clinical Interventions,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 1, 2025
Abstract
INTRODUCTION
Recruitment
of
participants
for
intervention
studies
is
challenging.
We
evaluated
the
effectiveness
and
efficiency
a
participant
recruitment
campaign
through
an
online
registry
FINGER‐NL
study,
multi‐domain
lifestyle
trial
targeting
cognitively
healthy
individuals
aged
60–79
with
dementia
prevention
potential.
Additionally,
we
explored
which
strategy
successfully
reached
from
underrepresented
groups
in
research.
METHODS
The
entailed
seven
strategies
referring
to
Dutch
Brain
Research
Registry
(DBRR):
(1)
Facebook
advertisements,
(2)
appearance
on
national
television,
(3)
newspaper
articles,
(4)
researcher
outreach,
(5)
patient
organizations,
(6)
search
engines,
(7)
other.
For
each
strategy,
describe
number
(a)
registered,
(b)
potentially
eligible,
(c)
included
FINGER‐NL.
Subsequently,
efficiency,
defined
by
eligibility
ratio
(eligible/registered),
effectiveness,
inclusion
(included/registered)
were
calculated.
Associations
between
sociodemographic
factors
tested
binomial
logistic
regressions.
RESULTS
resulted
13,795
new
DBRR
registrants,
n
=
3475
eligible
(eligibility
0.25)
1008
(inclusion
0.07).
advertisements
television
highest
numbers
registrants
(
4678
2182)
translated
inclusions
288
262).
0.35),
articles
(0.26),
campaigns
(0.26)
most
efficient
strategies.
0.13)
was
effective
strategy.
performed
relatively
better
recruiting
groups.
DISCUSSION
A
multipronged
via
prescreening
adequate
years
potential
multi‐site
within
limited
time
frame
15
months.
Social
media
are
preferred
recruit
Highlights
An
brain
research
recruited
successfully.
Mass
reaching
large
numbers.
Direct
researchers
organizations
seems
more
effective.
Online
registries
offer
automated
alternatives
screen‐failures.
Tailored
needed
reach
improve
diversity.
Frontiers in Science,
Journal Year:
2025,
Volume and Issue:
3
Published: March 25, 2025
Age-related
neurodegenerative
disorders,
including
dementia,
are
a
major
global
health
concern.
This
article
describes
the
first
comprehensive,
data-driven
molecular
model
of
neuro-glia-vascular
system
to
explore
complex
relationships
between
aging
brain,
energy
metabolism,
blood
flow,
and
neuronal
activity.
Comprising
16,800
interaction
pathways,
includes
all
key
enzymes,
transporters,
metabolites,
circulatory
factors
vital
for
electrical
We
found
significant
alterations
in
metabolite
concentrations
differential
effects
on
adenosine
triphosphate
(ATP)
supply
neurons
astrocytes
within
subcellular
compartments
aged
brains
identified
reduced
sodium/potassium
triphosphatase
(Na
+
/K
-ATPase)
activity
as
leading
cause
impaired
action
potentials.
The
predicts
that
metabolic
pathways
cluster
more
closely
suggesting
loss
robustness
adaptability.
Additionally,
displays
flexibility,
undermining
its
capacity
efficiently
respond
stimuli
recover
from
damage.
Through
transcription
factor
analysis,
estrogen-related
receptor
alpha
(ESRRA)
emerged
central
target
connected
these
aging-related
changes.
An
unguided
optimization
search
pinpointed
potential
interventions
capable
restoring
brain’s
flexibility
generation.
These
strategies
include
increasing
nicotinamide
adenine
dinucleotide
(NADH)
cytosol-mitochondria
shuttle,
NAD
pool,
ketone
β-hydroxybutyrate,
lactate,
Na
-ATPase,
while
reducing
glucose
levels.
is
open
sourced
help
guide
further
research
into
brain
metabolism.
The Lancet Healthy Longevity,
Journal Year:
2024,
Volume and Issue:
5(2), P. e120 - e130
Published: Feb. 1, 2024
Summary
Background
It
is
unknown
whether
multidomain
interventions,
which
might
preserve
late-life
cognition,
affect
Alzheimer's
disease
pathology.
Previous
studies
measured
cerebrospinal
fluid
and
imaging
biomarkers
in
small
subsamples
of
trial
participants.
Newly
developed
assays
enable
the
measurement
blood-based
larger
samples.
We
aimed
to
assess
plasma
tau
phosphorylated
at
threonine
181
(p-tau181)
was
able
detect
or
predict
3-year
intervention
effects.
Methods
This
a
secondary
analysis
randomised,
controlled,
Multidomain
Alzheimer
Prevention
Trial
(MAPT)
testing
intervention,
omega-3
fatty
acid
supplementation,
both
versus
placebo,
individuals
aged
70
years
older
13
memory
centres
France
Monaco.
Plasma
p-tau181
stored
blood
samples
subsample
527
participants
on
an
intention-to-treat
basis.
Changes
cognitive
score
were
calculated
as
composite
measure
using
average
Z
scores
for
following
tests:
Mini
Mental
State
Examination
orientation
items,
Free
Cued
Selective
Reminding
Test
(sum
free
total
recall
scores),
category
fluency,
Digit
Symbol
Substitution
Test.
Intervention
effects
change
concentration
estimated
by
use
linear
mixed
model
with
centre-specific
random
intercepts.
Findings
Recruitment
took
place
between
May
30,
2008,
Feb
24,
2011.
Median
baseline
8·8
pg/mL
(IQR
6·7–11·9)
sample,
significantly
higher
individuals,
men,
APOE
ε4
carriers,
renal
dysfunction
positive
PET
amyloid
scan.
During
follow-up,
raised
underwent
greater
decline
(eg,
mean
difference
control
group
normal
abnormal
levels
p-tau
−0·34
[effect
size
−0·52;
95%
CI
−0·61
0·07]
fully
adjusted
12·4
cutoff
p-tau181),
but
there
no
either
this
subgroup
population,
effect
abnormality,
[95%
CI]
+
group,
was,
respectively:
0·13
[−0·21
0·47],
0·03
[−0·30
0·36],
0·10
[−0·26
0·46]).
Surprisingly,
showed
decrease
during
follow-up
unadjusted
−3·01
(−4·45
−1·56)
subjects
[using
cutoff]).
Interpretation
Our
results
support
utility
prognostic
biomarker,
it
did
not
study.
Further
investigation
its
usefulness
prevention
outcome
required.
Funding
Toulouse
Gérontopôle,
French
Ministry
Health
Pierre
Fabre
Research
Institute.
Frontiers in Aging Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: Feb. 7, 2024
Introduction
Modifiable
risk
factors
account
for
a
substantial
proportion
of
Alzheimer’s
disease
(AD)
cases
and
we
currently
have
discrete
AT(N)
biomarker
profile
AD
biomarkers:
amyloid
(A),
p-tau
(T),
neurodegeneration
(N).
Here,
investigated
how
modifiable
relate
to
the
three
hallmark
biomarkers
AD.
Methods
Participants
from
European
Prevention
Dementia
(EPAD)
study
underwent
clinical
assessments,
brain
magnetic
resonance
imaging,
cerebrospinal
fluid
collection
analysis.
Generalized
additive
models
(GAMs)
with
penalized
regression
splines
were
modeled
in
Workbench
on
NTKApp.
Results
A
total
1,434
participants
included
(56%
women,
39%
APOE
ε4+)
an
average
age
65.5
(±
7.2)
years.
We
found
that
less
education
(
t
=
3.9,
p
<
0.001),
exercise
2.1,
0.034),
traumatic
injury
−2.1,
0.036),
higher
body
mass
index
−4.5,
0.001)
all
significantly
associated
burden.
Discussion
This
cross-sectional
provides
further
support
displaying
neuroprotective
associations
characteristic